End-of-radiation PSA as a novel prognostic factor in patients undergoing definitive radiation and androgen deprivation therapy for prostate cancer

BACKGROUND: In men undergoing definitive radiation for prostate cancer, it is unclear whether early biochemical response can provide additional prognostic value beyond pre-treatment risk stratification. METHODS: Prostate cancer patients consecutively treated with definitive radiation at our institut...

Descripción completa

Detalles Bibliográficos
Autores principales: Narang, Amol K., Trieu, Janson, Radwan, Noura, Ram, Ashwin, Robertson, Scott P., He, Pei, Gergis, Carol, Griffith, Emily, Singh, Harleen, DeWeese, Tate A., Honig, Stephanie, Annadanam, Anvesh, Greco, Stephen, DeVille, Curtiland, McNutt, Todd, DeWeese, Theodore L., Song, Daniel Y., Tran, Phuoc T.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: 2017
Materias:
Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429233/
https://www.ncbi.nlm.nih.gov/pubmed/28094250
http://dx.doi.org/10.1038/pcan.2016.67

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5429233/
https://www.ncbi.nlm.nih.gov/pubmed/28094250
http://dx.doi.org/10.1038/pcan.2016.67

Ejemplares similares